| | | SB 218078
CAS:135897-06-2
Formula: C24 H15 N3 O3
TRC-S155068
393.394
SB 218078; 9,10,11,12-Tetrahydro-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-1,3(2H)-dione SB 224289
CAS:180083-23-2
Formula: C32H32N4O3
TRC-S154610
520.62
[2'-Methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl](2,5,6,7-tetrahydro-1'-methylspiro[3H-furo[2,3-f]indole-3,4'-piperidin]-5-yl)-methanone; SB 224289; [4-[2-Methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]phenyl]-(1'-methylspi SB 264128
CAS:202585-70-4
Formula: C28 H42 N2 O5 . H Cl
TRC-S154640
523.104
SB 264128; [(1S,3R,4S)-1-Azabicyclo[2.2.1]hept-3-ylcarbonyl]-carbamic Acid (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl Ester Monohydrochloride SBS-1000-D5
Formula: C26 D5 H21 I2 N2 O4
TRC-S215702
689.335
SBS-1000-D5; N-((4R,4aS,7R,7aR,12bS)-3-(Allyl-d5)-4a,9-dihydroxy-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)-3,4-diiodobenzamide; SCHISANDRIN C
CAS:61301-33-5
Formula: C22 H24 O6
TRC-S199050
384.422
Schisandrin C; 5,6,7,8-Tetrahydro-13,14-dimethoxy-6,7-dimethyl-cycloocta[1,2-f:3,4-f']bis[1,3]benzodioxole Stereoisomer; (6R,7S,13aS)-5,6,7,8-Tetrahydro-13,14-dimethoxy-6,7-dimethylcycloocta[1,2-f:3,4-f']bis[1,3]benzodioxole; (-)-Schisandri SCHISANTHERIN A
CAS:58546-56-8
Formula: C30 H32 O9
TRC-S199100-50mg
536.57
Benzo[3,4]cycloocta[1,2-f][1,3]benzodioxole-5,6-diol, 5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-, 5-benzoate, (5S,6S,7S,13aS)-; Benzo[3,4]cycloocta[1,2-f][1,3]benzodioxole-5,6-diol, 5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-d SCHISANTHERIN B
CAS:58546-55-7
Formula: C28 H34 O9
TRC-S199110-10mg
514.56
2-Butenoic acid, 2-methyl-, (5S,6S,7S,13aS)-5,6,7,8-tetrahydro-6-hydroxy-1,2,3,13-tetramethoxy-6,7-dimethylbenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-5-yl ester, (2Z)-; 2-Butenoic acid, 2-methyl-, 5,6,7,8-tetrahydro-6-hydroxy-1,2,3,13-tetra SCHISANTHERIN B
CAS:58546-55-7
Formula: C28 H34 O9
TRC-S199110-5mg
514.56
2-Butenoic acid, 2-methyl-, (5S,6S,7S,13aS)-5,6,7,8-tetrahydro-6-hydroxy-1,2,3,13-tetramethoxy-6,7-dimethylbenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-5-yl ester, (2Z)-; 2-Butenoic acid, 2-methyl-, 5,6,7,8-tetrahydro-6-hydroxy-1,2,3,13-tetra SCHISANTHERIN B
CAS:58546-55-7
Formula: C28 H34 O9
TRC-S199110-50mg
514.56
2-Butenoic acid, 2-methyl-, (5S,6S,7S,13aS)-5,6,7,8-tetrahydro-6-hydroxy-1,2,3,13-tetramethoxy-6,7-dimethylbenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-5-yl ester, (2Z)-; 2-Butenoic acid, 2-methyl-, 5,6,7,8-tetrahydro-6-hydroxy-1,2,3,13-tetra SCHISANTHERIN E
CAS:64917-83-5
Formula: C30H34O9
TRC-S199105-2.5mg
538.59
Schizantherin E; 5,6,7,8-Tetrahydro-1,2,10,11,12-pentamethoxy-6,7-dimethyl-dibenzo[a,c]cyclooctene-3,7,8-triol-8-benzoate Stereoisomer; SCHIZANDRIN A
CAS:61281-38-7
Formula: C24 H32 O6
TRC-S199945-10mg
416.51
Dibenzo[a,c]cyclooctene, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, (6R,7S,12aR)-; Dibenzo[a,c]cyclooctene, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, stereoisomer; (+)-Deoxyschizandrin; (6R,7S,12aR)-5,6, SCHIZANDRIN A
CAS:61281-38-7
Formula: C24 H32 O6
TRC-S199945-250mg
416.51
Dibenzo[a,c]cyclooctene, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, (6R,7S,12aR)-; Dibenzo[a,c]cyclooctene, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, stereoisomer; (+)-Deoxyschizandrin; (6R,7S,12aR)-5,6, SCHIZANDRIN A
CAS:61281-38-7
Formula: C24 H32 O6
TRC-S199945-50mg
416.51
Dibenzo[a,c]cyclooctene, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, (6R,7S,12aR)-; Dibenzo[a,c]cyclooctene, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, stereoisomer; (+)-Deoxyschizandrin; (6R,7S,12aR)-5,6, SCHIZANDROL
CAS:7432-28-2
Formula: C24 H32 O7
TRC-S199905-10mg
432.51
Dibenzo[a,c]cycloocten-6-ol, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, (6S,7S,12aR)-; Schizandrin (7CI); (+)-Schizandrin; (6S,7S,12aR)-5,6,7,8-Tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyldibenzo[a,c]cycloocten-6-ol; SCHIZANDROL
CAS:7432-28-2
Formula: C24 H32 O7
TRC-S199905-50mg
432.51
Dibenzo[a,c]cycloocten-6-ol, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, (6S,7S,12aR)-; Schizandrin (7CI); (+)-Schizandrin; (6S,7S,12aR)-5,6,7,8-Tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyldibenzo[a,c]cycloocten-6-ol; SCHIZANDROL
CAS:7432-28-2
Formula: C24 H32 O7
TRC-S199905-250mg
432.51
Dibenzo[a,c]cycloocten-6-ol, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, (6S,7S,12aR)-; Schizandrin (7CI); (+)-Schizandrin; (6S,7S,12aR)-5,6,7,8-Tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyldibenzo[a,c]cycloocten-6-ol; SCILLARENIN
CAS:465-22-5
Formula: C24 H32 O4
TRC-S199960-1mg
384.51
Bufa-4,20,22-trienolide, 3,14-dihydroxy-, (3+¦)-; Bufa-4,20,22-trienolide, 3+¦,14-dihydroxy- (7CI,8CI); Scillarenin (6CI); (3+¦)-3,14-Dihydroxybufa-4,20,22-trienolide; 3+¦-Scillarenin; Cardiogenin; NSC 234669; Scillarenin A; Scillarenine; +¦-Sci SCILLARENIN
CAS:465-22-5
Formula: C24 H32 O4
TRC-S199960-10mg
384.51
Bufa-4,20,22-trienolide, 3,14-dihydroxy-, (3+¦)-; Bufa-4,20,22-trienolide, 3+¦,14-dihydroxy- (7CI,8CI); Scillarenin (6CI); (3+¦)-3,14-Dihydroxybufa-4,20,22-trienolide; 3+¦-Scillarenin; Cardiogenin; NSC 234669; Scillarenin A; Scillarenine; +¦-Sci SCLAREOL DIACETATE
CAS:54274-72-5
Formula: C7 H15 N O4
TRC-S200055-250mg
177.198
[1R-[1+¦(R*),2+¦,4a+¦,8a+¦]]-2-(Acetyloxy)-+¦-ethenyldecahydro-+¦,2,5,5,8a-pentamethyl-1-naphthalenepropanol Acetate; (+¦R,1R,2R,4aS,8aS)-2-(Acetyloxy)-+¦-ethenyldecahydro-+¦,2,5,5,8a-pentamethyl-1-naphthalenepropanol Acetate; (+¦R,1R,2R,4aS,8aS)-2-( SCLAREOL DIACETATE
CAS:54274-72-5
Formula: C7 H15 N O4
TRC-S200055-100mg
177.198
[1R-[1+¦(R*),2+¦,4a+¦,8a+¦]]-2-(Acetyloxy)-+¦-ethenyldecahydro-+¦,2,5,5,8a-pentamethyl-1-naphthalenepropanol Acetate; (+¦R,1R,2R,4aS,8aS)-2-(Acetyloxy)-+¦-ethenyldecahydro-+¦,2,5,5,8a-pentamethyl-1-naphthalenepropanol Acetate; (+¦R,1R,2R,4aS,8aS)-2-( SCLAREOL DIACETATE
CAS:54274-72-5
Formula: C7 H15 N O4
TRC-S200055-500mg
177.198
[1R-[1+¦(R*),2+¦,4a+¦,8a+¦]]-2-(Acetyloxy)-+¦-ethenyldecahydro-+¦,2,5,5,8a-pentamethyl-1-naphthalenepropanol Acetate; (+¦R,1R,2R,4aS,8aS)-2-(Acetyloxy)-+¦-ethenyldecahydro-+¦,2,5,5,8a-pentamethyl-1-naphthalenepropanol Acetate; (+¦R,1R,2R,4aS,8aS)-2-( SCOPARONE
CAS:120-08-1
Formula: C11 H10 O4
TRC-S199980-500mg
206.19
2H-1-Benzopyran-2-one, 6,7-dimethoxy-; Coumarin, 6,7-dimethoxy- (6CI,7CI,8CI); 6,7-Dimethoxy-2H-1-benzopyran-2-one; 6,7-Dimethoxy-2H-chromen-2-one; 6,7-Dimethoxycoumarin; 6,7-Dimethylesculetin; Aesculetin dimethyl ether; Escoparone; Esculet SCOPARONE
CAS:120-08-1
Formula: C11 H10 O4
TRC-S199980-1g
206.19
2H-1-Benzopyran-2-one, 6,7-dimethoxy-; Coumarin, 6,7-dimethoxy- (6CI,7CI,8CI); 6,7-Dimethoxy-2H-1-benzopyran-2-one; 6,7-Dimethoxy-2H-chromen-2-one; 6,7-Dimethoxycoumarin; 6,7-Dimethylesculetin; Aesculetin dimethyl ether; Escoparone; Esculet SCOPARONE
CAS:120-08-1
Formula: C11 H10 O4
TRC-S199980-25mg
206.19
2H-1-Benzopyran-2-one, 6,7-dimethoxy-; Coumarin, 6,7-dimethoxy- (6CI,7CI,8CI); 6,7-Dimethoxy-2H-1-benzopyran-2-one; 6,7-Dimethoxy-2H-chromen-2-one; 6,7-Dimethoxycoumarin; 6,7-Dimethylesculetin; Aesculetin dimethyl ether; Escoparone; Esculet SCOPIN
CAS:498-45-3
Formula: C8 H13 N O2
TRC-S199977-25mg
155.19
(1+¦,2+¦,4+¦,5+¦,7+¦)-9-methyl-3-Oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol; 1+¦H,5+¦H-Tropan-3+¦-ol, 6+¦,7+¦-epoxy- (8CI); Scopine (6CI,7CI); (1+¦,2+¦,4+¦,5+¦,7+¦)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol; 6,7-Epoxytropine; Scopanol; Scopin SCOPIN
CAS:498-45-3
Formula: C8 H13 N O2
TRC-S199977-10mg
155.19
(1+¦,2+¦,4+¦,5+¦,7+¦)-9-methyl-3-Oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol; 1+¦H,5+¦H-Tropan-3+¦-ol, 6+¦,7+¦-epoxy- (8CI); Scopine (6CI,7CI); (1+¦,2+¦,4+¦,5+¦,7+¦)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol; 6,7-Epoxytropine; Scopanol; Scopin SCOPIN
CAS:498-45-3
Formula: C8 H13 N O2
TRC-S199977-50mg
155.19
(1+¦,2+¦,4+¦,5+¦,7+¦)-9-methyl-3-Oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol; 1+¦H,5+¦H-Tropan-3+¦-ol, 6+¦,7+¦-epoxy- (8CI); Scopine (6CI,7CI); (1+¦,2+¦,4+¦,5+¦,7+¦)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol; 6,7-Epoxytropine; Scopanol; Scopin SCOPINE DI(2-THIENYLGLYCOLATE)
CAS:136310-64-0
Formula: C18 H19 N O4 S2
TRC-S199965-100mg
377.48
2-Thiopheneacetic acid, +¦-hydroxy-+¦-2-thienyl-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, (1+¦,2+¦,4+¦,5+¦,7+¦)-; (1+¦,2+¦,4+¦,5+¦,7+¦)-7-[(Hydroxydi(2-thienyl)acetyl)oxy]-9-methyl-3-oxa-9-azatricyclo[3.3.1.0]nonane; Di(2-thienyl)glycol SCOPINE DI(2-THIENYLGLYCOLATE)
CAS:136310-64-0
Formula: C18 H19 N O4 S2
TRC-S199965-10mg
377.48
2-Thiopheneacetic acid, +¦-hydroxy-+¦-2-thienyl-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, (1+¦,2+¦,4+¦,5+¦,7+¦)-; (1+¦,2+¦,4+¦,5+¦,7+¦)-7-[(Hydroxydi(2-thienyl)acetyl)oxy]-9-methyl-3-oxa-9-azatricyclo[3.3.1.0]nonane; Di(2-thienyl)glycol SCOPINE DI(2-THIENYLGLYCOLATE)
CAS:136310-64-0
Formula: C18 H19 N O4 S2
TRC-S199965-1g
377.48
2-Thiopheneacetic acid, +¦-hydroxy-+¦-2-thienyl-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, (1+¦,2+¦,4+¦,5+¦,7+¦)-; (1+¦,2+¦,4+¦,5+¦,7+¦)-7-[(Hydroxydi(2-thienyl)acetyl)oxy]-9-methyl-3-oxa-9-azatricyclo[3.3.1.0]nonane; Di(2-thienyl)glycol SCOPINE HYDROCHLORIDE
CAS:85700-55-6
Formula: C8 H13 N O2 . Cl H
TRC-S199975-1g
191.66
3-Oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol, 9-methyl-, hydrochloride (1:1), (1+¦,2+¦,4+¦,5+¦,7+¦)-; 3-Oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol, 9-methyl-, hydrochloride, (1+¦,2+¦,4+¦,5+¦,7+¦)- (9CI); Scopine hydrochloride SCOPINE HYDROCHLORIDE
CAS:85700-55-6
Formula: C8 H13 N O2 . Cl H
TRC-S199975-50mg
191.66
3-Oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol, 9-methyl-, hydrochloride (1:1), (1+¦,2+¦,4+¦,5+¦,7+¦)-; 3-Oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol, 9-methyl-, hydrochloride, (1+¦,2+¦,4+¦,5+¦,7+¦)- (9CI); Scopine hydrochloride SCOPINE HYDROCHLORIDE
CAS:85700-55-6
Formula: C8 H13 N O2 . Cl H
TRC-S199975-250mg
191.66
3-Oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol, 9-methyl-, hydrochloride (1:1), (1+¦,2+¦,4+¦,5+¦,7+¦)-; 3-Oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol, 9-methyl-, hydrochloride, (1+¦,2+¦,4+¦,5+¦,7+¦)- (9CI); Scopine hydrochloride SCOPINE METHOBROMIDE
CAS:1508-46-9
Formula: C9 H16 N O2 . Br
TRC-S199985-2.5mg
250.13
(1R,2R,4S,5S,7s)-7-Hydroxy-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide; 1+¦H,5+¦H-Tropanium, 6+¦,7+¦-epoxy-3+¦-hydroxy-8-methyl-, bromide (8CI); 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-hydroxy-9,9-dimethyl-, bromide, (1+¦,2+¦ SCOPINE METHOBROMIDE
CAS:1508-46-9
Formula: C9 H16 N O2 . Br
TRC-S199985-100mg
250.13
(1R,2R,4S,5S,7s)-7-Hydroxy-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide; 1+¦H,5+¦H-Tropanium, 6+¦,7+¦-epoxy-3+¦-hydroxy-8-methyl-, bromide (8CI); 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-hydroxy-9,9-dimethyl-, bromide, (1+¦,2+¦ SCOPINE METHOBROMIDE
CAS:1508-46-9
Formula: C9 H16 N O2 . Br
TRC-S199985-10mg
250.13
(1R,2R,4S,5S,7s)-7-Hydroxy-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide; 1+¦H,5+¦H-Tropanium, 6+¦,7+¦-epoxy-3+¦-hydroxy-8-methyl-, bromide (8CI); 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-hydroxy-9,9-dimethyl-, bromide, (1+¦,2+¦ SCOPOLAMINE
CAS:51-34-3
Formula: C17 H21 N O4
TRC-S200005-1g
303.35
Hyoscine; (1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate; Benzeneacetic acid, +¦-(hydroxymethyl)-, (1+¦,2+¦,4+¦,5+¦,7+¦)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, (+¦S)-; 1+¦H,5+¦H-T SCOPOLAMINE
CAS:51-34-3
Formula: C17 H21 N O4
TRC-S200005-100mg
303.35
Hyoscine; (1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate; Benzeneacetic acid, +¦-(hydroxymethyl)-, (1+¦,2+¦,4+¦,5+¦,7+¦)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, (+¦S)-; 1+¦H,5+¦H-T SCOPOLAMINE
CAS:51-34-3
Formula: C17 H21 N O4
TRC-S200005-500mg
303.35
Hyoscine; (1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate; Benzeneacetic acid, +¦-(hydroxymethyl)-, (1+¦,2+¦,4+¦,5+¦,7+¦)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, (+¦S)-; 1+¦H,5+¦H-T SCOPOLAMINE N-OXIDE
CAS:97-75-6
Formula: C17H21NO5
TRC-S200020-10mg
319.35
(+¦S)-+¦-(Hydroxymethyl)benzeneacetic Acid (1+¦,2+¦,4+¦,5+¦,7+¦)-9-Methyl-9-oxido-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl Ester; 6+¦,7+¦-Epoxy-1+¦H,5+¦H-tropan-3+¦-ol (-)-Tropate 8-Oxide; [7(S)-(1+¦,2+¦,4+¦,5+¦,7+¦)]-+¦-(Hydroxymethyl)benzeneacetic Acid 9-Me SCOPOLAMINE N-OXIDE
CAS:97-75-6
Formula: C17H21NO5
TRC-S200020-100mg
319.35
(+¦S)-+¦-(Hydroxymethyl)benzeneacetic Acid (1+¦,2+¦,4+¦,5+¦,7+¦)-9-Methyl-9-oxido-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl Ester; 6+¦,7+¦-Epoxy-1+¦H,5+¦H-tropan-3+¦-ol (-)-Tropate 8-Oxide; [7(S)-(1+¦,2+¦,4+¦,5+¦,7+¦)]-+¦-(Hydroxymethyl)benzeneacetic Acid 9-Me SCOPOLAMINE N-OXIDE-D3
Formula: C17 D3 H18 N O5
TRC-S200022
322.371
(+¦S)-+¦-(Hydroxymethyl)benzeneacetic Acid (1+¦,2+¦,4+¦,5+¦,7+¦)-9-Methyl-9-oxido-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl Ester-d3; 6+¦,7+¦-Epoxy-1+¦H,5+¦H-tropan-3+¦-ol (-)-Tropate 8-Oxide-d3; [7(S)-(1+¦,2+¦,4+¦,5+¦,7+¦)]-+¦-(Hydroxymethyl)benzeneacetic Aci SCOPOLINE
CAS:487-27-4
Formula: C8H13NO2
TRC-S201428-500mg
155.19
1+¦H,5+¦H-Tropan-6+¦-ol, 3+¦,7+¦-epoxy- (8CI); 2,5-Methano-2H-furo[3,2-b]pyrrol-6-ol, hexahydro-4-methyl-, (2+¦,3a+¦,5+¦,6+¦,6a+¦)-; Scopoline (6CI,7CI); rel-(2R,3aS,5R,6R,6aR)-Hexahydro-4-methyl-2,5-methano-2H-furo[3,2-b]pyrrol-6-ol; (-¦)-Scopoline; SCOPOLINE
CAS:487-27-4
Formula: C8H13NO2
TRC-S201428-50mg
155.19
1+¦H,5+¦H-Tropan-6+¦-ol, 3+¦,7+¦-epoxy- (8CI); 2,5-Methano-2H-furo[3,2-b]pyrrol-6-ol, hexahydro-4-methyl-, (2+¦,3a+¦,5+¦,6+¦,6a+¦)-; Scopoline (6CI,7CI); rel-(2R,3aS,5R,6R,6aR)-Hexahydro-4-methyl-2,5-methano-2H-furo[3,2-b]pyrrol-6-ol; (-¦)-Scopoline; SCOPOLINE
CAS:487-27-4
Formula: C8H13NO2
TRC-S201428-100mg
155.19
1+¦H,5+¦H-Tropan-6+¦-ol, 3+¦,7+¦-epoxy- (8CI); 2,5-Methano-2H-furo[3,2-b]pyrrol-6-ol, hexahydro-4-methyl-, (2+¦,3a+¦,5+¦,6+¦,6a+¦)-; Scopoline (6CI,7CI); rel-(2R,3aS,5R,6R,6aR)-Hexahydro-4-methyl-2,5-methano-2H-furo[3,2-b]pyrrol-6-ol; (-¦)-Scopoline; Scutellarein (>90%)
CAS:529-53-3
Formula: C15 H10 O6
TRC-S201890-50mg
286.24
4H-1-Benzopyran-4-one, 5,6,7-trihydroxy-2-(4-hydroxyphenyl)-; Flavone, 4',5,6,7-tetrahydroxy- (7CI,8CI); Scutellarein (6CI); 4',5,6,7-Tetrahydroxyflavone; 5,6,7,4'-Tetrahydroxyflavone; 5,6,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4- Scutellarein (>90%)
CAS:529-53-3
Formula: C15 H10 O6
TRC-S201890-25mg
286.24
4H-1-Benzopyran-4-one, 5,6,7-trihydroxy-2-(4-hydroxyphenyl)-; Flavone, 4',5,6,7-tetrahydroxy- (7CI,8CI); Scutellarein (6CI); 4',5,6,7-Tetrahydroxyflavone; 5,6,7,4'-Tetrahydroxyflavone; 5,6,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4- Scutellarein (>90%)
CAS:529-53-3
Formula: C15 H10 O6
TRC-S201890-10mg
286.24
4H-1-Benzopyran-4-one, 5,6,7-trihydroxy-2-(4-hydroxyphenyl)-; Flavone, 4',5,6,7-tetrahydroxy- (7CI,8CI); Scutellarein (6CI); 4',5,6,7-Tetrahydroxyflavone; 5,6,7,4'-Tetrahydroxyflavone; 5,6,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4- SCUTELLAREIN-6,4'-DIMETHYL ETHER
CAS:520-12-7
Formula: C17 H14 O6
TRC-S213595
314.289
Scutellarein-6,4'-dimethyl Ether; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-6-methoxy-2-(4-methoxyphenyl)-; Flavone, 5,7-dihydroxy-4',6-dimethoxy- (7CI,8CI); Pectolinarigenin (6CI); 4'-O-Methylcapillarisin; 5,7-Dihydroxy-4',6-dimethoxyflavone; 5 SDC-TRAP 0063
CAS:1472614-83-7
Formula: C49 H49 N7 O9
TRC-S147260
879.955
SDC-TRAP 0063; (4S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-[2-[5-[3-[2,4-dihydroxy-5-(1-methylethyl)phenyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]-1H-indol-1-yl]ethyl]-1 SDG-SIL
Formula: C32 H46 O16
TRC-S210065
686.698
SDG-SIL; (2S,2'S,3R,3'R,4R,4'R,5S,5'S,6S,6'S)-6,6'-((2,3-bis(4-Hydroxy-3-methoxybenzyl)butane-1,4-diyl)bis(oxy))bis(2-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol) SDZ SER 082
CAS:141474-54-6
Formula: C15 H20 N2 . C4 H4 O4
TRC-S211100
344.405
SDZ SER 082; (7aR,11aS)-rel-4,5,7a,8,9,10,11,11a-Octahydro-10-methyl-7H-indolo[1,7-bc][2,6]naphthyridine SDZ SER 082-D5
Formula: C15 D5 H15 N2
TRC-S211102
233.363
SDZ SER 082-D5; (7aR,11aS)-rel-4,5,7a,8,9,10,11,11a-Octahydro-10-methyl-7H-indolo[1,7-bc][2,6]naphthyridine-D5 SEBUTHYLAZIN-DESETHYL
CAS:37019-18-4
Formula: C7 H12 Cl N5
TRC-S211418
201.66
Sebuthylazine-desethyl; 1,3,5-Triazine-2,4-diamine, 6-chloro-N2-(1-methylpropyl)- (ACI); 1,3,5-Triazine-2,4-diamine, 6-chloro-N-(1-methylpropyl)- (9CI); 6-Chloro-N2-(1-methylpropyl)-1,3,5-triazine-2,4-diamine (ACI); 1,3,5-Triazine-2,4-diami SECALCIFEROL
CAS:55721-11-4
Formula: C27 H44 O3
TRC-S211500-10mg
416.64
2,3-Heptanediol, 2-methyl-6-[(1R,3aS,4E,7aR)-octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-1H-inden-1-yl]-, (3R,6R)-; 9,10-Secocholesta-5,7,10(19)-triene-3,24,25-triol, (3+¦,5Z,7E,24R)- (9CI); (3R,6R)-2 SECALCIFEROL
CAS:55721-11-4
Formula: C27 H44 O3
TRC-S211500-5mg
416.64
2,3-Heptanediol, 2-methyl-6-[(1R,3aS,4E,7aR)-octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-1H-inden-1-yl]-, (3R,6R)-; 9,10-Secocholesta-5,7,10(19)-triene-3,24,25-triol, (3+¦,5Z,7E,24R)- (9CI); (3R,6R)-2 SECALCIFEROL
CAS:55721-11-4
Formula: C27 H44 O3
TRC-S211500-1mg
416.64
2,3-Heptanediol, 2-methyl-6-[(1R,3aS,4E,7aR)-octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-1H-inden-1-yl]-, (3R,6R)-; 9,10-Secocholesta-5,7,10(19)-triene-3,24,25-triol, (3+¦,5Z,7E,24R)- (9CI); (3R,6R)-2 SECBUMETON
CAS:26259-45-0
Formula: C10 H19 N5 O
TRC-S241010
225.29
1,3,5-Triazine-2,4-diamine, N2-ethyl-6-methoxy-N4-(1-methylpropyl)- (ACI); 1,3,5-Triazine-2,4-diamine, N-ethyl-6-methoxy-N'-(1-methylpropyl)- (9CI); N2-Ethyl-6-methoxy-N4-(1-methylpropyl)-1,3,5-triazine-2,4-diamine (ACI); s-Triazine, 2-(sec SECBUTABARBITAL-D5
CAS:1215565-64-2
Formula: C10 2H5 H11 N2 O3
TRC-B689922-10mg
217.28
5-Butan-2-yl-5-(1,1,2,2,2-pentadeuterioethyl)-1,3-diazinane-2,4,6-trione; Butabarbital-d5; 5-(Ethyl-d5)-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione SECBUTABARBITAL-D5
CAS:1215565-64-2
Formula: C10 2H5 H11 N2 O3
TRC-B689922-1mg
217.28
5-Butan-2-yl-5-(1,1,2,2,2-pentadeuterioethyl)-1,3-diazinane-2,4,6-trione; Butabarbital-d5; 5-(Ethyl-d5)-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione SECBUTABARBITAL-D5
CAS:1215565-64-2
Formula: C10 2H5 H11 N2 O3
TRC-B689922-5MG
217.28
5-Butan-2-yl-5-(1,1,2,2,2-pentadeuterioethyl)-1,3-diazinane-2,4,6-trione; Butabarbital-d5; 5-(Ethyl-d5)-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione seco Everolimus B (>85%)
CAS:769905-89-7
Formula: C53H85NO15
TRC-E945410-5mg
976.24
(2S)-1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-Dihydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15-docosatetraen-1-yl]tetrahydro-2-hyd seco Everolimus B (>85%)
CAS:769905-89-7
Formula: C53H85NO15
TRC-E945410-1mg
976.24
(2S)-1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-Dihydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15-docosatetraen-1-yl]tetrahydro-2-hyd seco Everolimus B (>85%)
CAS:769905-89-7
Formula: C53H85NO15
TRC-E945410-0.25mg
976.24
(2S)-1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-Dihydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15-docosatetraen-1-yl]tetrahydro-2-hyd SECORAPAMYCIN B
CAS:185107-79-3
Formula: C51H81NO14
TRC-S239555-2.5mg
932.19
[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-Dihydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15-docosatetraen-1-yl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]-2-oxo SECORAPAMYCIN B
CAS:185107-79-3
Formula: C51H81NO14
TRC-S239555-1mg
932.19
[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-Dihydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15-docosatetraen-1-yl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]-2-oxo SELINA-3,7(11)-DIENE
CAS:6813-21-4
Formula: C15H24
TRC-S253188-2.5mg
204.35
Eudesma-3,7(11)-diene; (4aR,8aR)-1,2,3,4,4a,5,6,8a-Octahydro-4a,8-dimethyl-2-(1-methylethylidene)naphthalene SELINA-3,7(11)-DIENE
CAS:6813-21-4
Formula: C15H24
TRC-S253188-0.5MG
204.35
Eudesma-3,7(11)-diene; (4aR,8aR)-1,2,3,4,4a,5,6,8a-Octahydro-4a,8-dimethyl-2-(1-methylethylidene)naphthalene SELINA-3,7(11)-DIENE
CAS:6813-21-4
Formula: C15H24
TRC-S253188-5mg
204.35
Eudesma-3,7(11)-diene; (4aR,8aR)-1,2,3,4,4a,5,6,8a-Octahydro-4a,8-dimethyl-2-(1-methylethylidene)naphthalene SENECIONINE N-OXIDE-D3
Formula: C18H22D3NO6
TRC-S258657-5mg
354.41
(3Z,5R,6R,14aR,14bR)-3-Ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione 12-Oxide-D3; 12-Hydroxy-senecionan-11,16-dione 4-Oxide-D3; NSC 106677-D3; Senecionine Oxide SENECIONINE N-OXIDE-D3
Formula: C18H22D3NO6
TRC-S258657-1mg
354.41
(3Z,5R,6R,14aR,14bR)-3-Ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione 12-Oxide-D3; 12-Hydroxy-senecionan-11,16-dione 4-Oxide-D3; NSC 106677-D3; Senecionine Oxide SENECIONINE N-OXIDE-D3
Formula: C18H22D3NO6
TRC-S258657-0.5mg
354.41
(3Z,5R,6R,14aR,14bR)-3-Ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione 12-Oxide-D3; 12-Hydroxy-senecionan-11,16-dione 4-Oxide-D3; NSC 106677-D3; Senecionine Oxide SENECIONINE-D3
Formula: C18H22D3NO5
TRC-S258652-2.5mg
338.41
(-)-Senecionine-D3; Aureine-D3; NSC 89935-D3; Senecionin-D3; [5R-(3Z,5R*,6R*,14aR*,14bR*)]-3-Ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione-D3; SENECIONINE-D3
Formula: C18H22D3NO5
TRC-S258652-0.25mg
338.41
(-)-Senecionine-D3; Aureine-D3; NSC 89935-D3; Senecionin-D3; [5R-(3Z,5R*,6R*,14aR*,14bR*)]-3-Ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione-D3; SENNOSIDE A
CAS:81-27-6
Formula: C42 H38 O20
TRC-S258805-250mg
862.74
[9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(+¦-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (9R,9'R)-; Sennoside A (6CI,7CI,8CI); [9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(+¦-D-glucopyranosylox SENNOSIDE A
CAS:81-27-6
Formula: C42 H38 O20
TRC-S258805-100mg
862.74
[9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(+¦-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (9R,9'R)-; Sennoside A (6CI,7CI,8CI); [9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(+¦-D-glucopyranosylox SENNOSIDE A
CAS:81-27-6
Formula: C42 H38 O20
TRC-S258805-50mg
862.74
[9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(+¦-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (9R,9'R)-; Sennoside A (6CI,7CI,8CI); [9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(+¦-D-glucopyranosylox SENNOSIDE B
CAS:128-57-4
Formula: C42 H38 O20
TRC-S258810-50mg
862.74
[9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(+¦-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (9R,9'S)-; Sennoside B (6CI,7CI,8CI); [9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(+¦-D-glucopyranosylox SENNOSIDE B
CAS:128-57-4
Formula: C42 H38 O20
TRC-S258810-25mg
862.74
[9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(+¦-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (9R,9'S)-; Sennoside B (6CI,7CI,8CI); [9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(+¦-D-glucopyranosylox SENNOSIDE B
CAS:128-57-4
Formula: C42 H38 O20
TRC-S258810-100mg
862.74
[9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(+¦-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (9R,9'S)-; Sennoside B (6CI,7CI,8CI); [9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(+¦-D-glucopyranosylox SENNOSIDE C
CAS:37271-16-2
Formula: C42H40O19
TRC-S258815
848.76
rel-(9R,9'R)-5,5'-Bis(+¦-D-Glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-2'-(hydroxymethyl)-10,10'-dioxo[9,9'-bianthracene]-2-carboxylic Acid; (R*,R*)-5,5'-bis(+¦-D-Glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-2'-(hydro SENNOSIDE D
CAS:37271-17-3
Formula: C42 H40 O19
TRC-S258820
848.756
Sennoside D; rel-(9R,9'S)-5,5'-Bis(+¦-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-2'-(hydroxymethyl)-10,10'-dioxo[9,9'-bianthracene]-2-carboxylic Acid; (R*,S*)-5,5'-Bis(+¦-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydr SERATRODAST
CAS:112665-43-7
Formula: C22 H26 O4
TRC-S263000-5mg
354.44
Benzeneheptanoic acid, +¦-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-; Benzeneheptanoic acid, +¦-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (-¦)-; +¦-(2,4,5-Trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)benzeneheptanoic acid; (-¦) SERATRODAST
CAS:112665-43-7
Formula: C22 H26 O4
TRC-S263000-10mg
354.44
Benzeneheptanoic acid, +¦-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-; Benzeneheptanoic acid, +¦-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (-¦)-; +¦-(2,4,5-Trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)benzeneheptanoic acid; (-¦) SERTRALINE HYDROCHLORIDE
CAS:79559-97-0
Formula: C17 H17 Cl2 N . Cl H
TRC-S280000-50mg
342.69
Sertraline Hydrochloride; (1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride (1:1); (1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride; (1S,4S)-4-(3,4-Dichloro SERTRALINE HYDROCHLORIDE
CAS:79559-97-0
Formula: C17 H17 Cl2 N . Cl H
TRC-S280000-100mg
342.69
Sertraline Hydrochloride; (1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride (1:1); (1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride; (1S,4S)-4-(3,4-Dichloro SERTRALINE HYDROCHLORIDE
CAS:79559-97-0
Formula: C17 H17 Cl2 N . Cl H
TRC-S280000-10mg
342.69
Sertraline Hydrochloride; (1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride (1:1); (1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride; (1S,4S)-4-(3,4-Dichloro SERTRALINE HYDROCHLORIDE (1.0 MG/ML IN METHANOL)
CAS:79559-97-0
Formula: C17 H17 Cl2 N . Cl H
TRC-KIT7820-5X1ML
342.69
Sertraline Hydrochloride; (1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride (1:1); (1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride; (1S,4S)-4-(3,4-Dichloro SESAMIN
CAS:607-80-7
Formula: C20 H18 O6
TRC-S280500-25mg
354.35
1,3-Benzodioxole, 5,5'-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis-, [1S-(1+¦,3a+¦,4+¦,6a+¦)]-; 1H,3H-Furo[3,4-c]furan, tetrahydro-1,4-bis[3,4-(methylenedioxy)phenyl]-, (1S,3aR,4S,6aR)- (8CI); (1S,3aR,4S,6aR)-5,5'-(Tetrahydro-1H,3H-furo[3,4 SESAMIN
CAS:607-80-7
Formula: C20 H18 O6
TRC-S280500-1mg
354.35
1,3-Benzodioxole, 5,5'-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis-, [1S-(1+¦,3a+¦,4+¦,6a+¦)]-; 1H,3H-Furo[3,4-c]furan, tetrahydro-1,4-bis[3,4-(methylenedioxy)phenyl]-, (1S,3aR,4S,6aR)- (8CI); (1S,3aR,4S,6aR)-5,5'-(Tetrahydro-1H,3H-furo[3,4 SESAMIN
CAS:607-80-7
Formula: C20 H18 O6
TRC-S280500-10mg
354.35
1,3-Benzodioxole, 5,5'-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis-, [1S-(1+¦,3a+¦,4+¦,6a+¦)]-; 1H,3H-Furo[3,4-c]furan, tetrahydro-1,4-bis[3,4-(methylenedioxy)phenyl]-, (1S,3aR,4S,6aR)- (8CI); (1S,3aR,4S,6aR)-5,5'-(Tetrahydro-1H,3H-furo[3,4 SETROBUVIR
CAS:1071517-39-9
Formula: C25 H25 F N4 O6 S2
TRC-S101220
560.618
Setrobuvir; N-[3-[(4aR,5S,8R,8aS)-1-[(4-Fluorophenyl)methyl]-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl]methanesulfonamide; SHANZHISIDE METHYL ESTER
CAS:64421-28-9
Formula: C17 H26 O11
TRC-S282390-1mg
406.38
Cyclopenta[c]pyran-4-carboxylic acid, 1-(+¦-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-5,7-dihydroxy-7-methyl-, methyl ester, (1S,4aS,5R,7S,7aS)-; Cyclopenta[c]pyran-4-carboxylic acid, 1-(+¦-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-5,7- SHANZHISIDE METHYL ESTER
CAS:64421-28-9
Formula: C17 H26 O11
TRC-S282390-2.5mg
406.38
Cyclopenta[c]pyran-4-carboxylic acid, 1-(+¦-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-5,7-dihydroxy-7-methyl-, methyl ester, (1S,4aS,5R,7S,7aS)-; Cyclopenta[c]pyran-4-carboxylic acid, 1-(+¦-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-5,7- SHANZHISIDE METHYL ESTER
CAS:64421-28-9
Formula: C17 H26 O11
TRC-S282390-5mg
406.38
Cyclopenta[c]pyran-4-carboxylic acid, 1-(+¦-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-5,7-dihydroxy-7-methyl-, methyl ester, (1S,4aS,5R,7S,7aS)-; Cyclopenta[c]pyran-4-carboxylic acid, 1-(+¦-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-5,7- SHIKIMIC ACID
CAS:138-59-0
Formula: C7 H10 O5
TRC-S357100-1g
174.15
1-Cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-, (3R,4S,5R)- (9CI, ACI); (3R,4S,5R)-3,4,5-Trihydroxy-1-cyclohexene-1-carboxylic acid (ACI); 1-Cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-, [3R-(3+¦,4+¦,5+¦)]- (ZCI); (-)-3,4,5-Trihydroxy- SHIKIMIC ACID
CAS:138-59-0
Formula: C7 H10 O5
TRC-S357100-2.5g
174.15
1-Cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-, (3R,4S,5R)- (9CI, ACI); (3R,4S,5R)-3,4,5-Trihydroxy-1-cyclohexene-1-carboxylic acid (ACI); 1-Cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-, [3R-(3+¦,4+¦,5+¦)]- (ZCI); (-)-3,4,5-Trihydroxy- SHIKIMIC ACID
CAS:138-59-0
Formula: C7 H10 O5
TRC-S357100-50mg
174.15
1-Cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-, (3R,4S,5R)- (9CI, ACI); (3R,4S,5R)-3,4,5-Trihydroxy-1-cyclohexene-1-carboxylic acid (ACI); 1-Cyclohexene-1-carboxylic acid, 3,4,5-trihydroxy-, [3R-(3+¦,4+¦,5+¦)]- (ZCI); (-)-3,4,5-Trihydroxy- SHVO'S CATALYST
CAS:104439-77-2
Formula: C62H42O6Ru2
TRC-S282400-500mg
1085.13
Tetracarbonyl-++-hydro[(1,2,3,4,5-++)-1-hydroxy-2,3,4,5-tetraphenyl-2,4-cyclopentadien-1-yl][(2,3,4,5-++)-2,3,4,5-tetraphenyl-2,4-cyclopentadien-1-one]di-ruthenium Coordination Compound; 2,3,4,5-Tetraphenyl-1,3-cyclopentadien-1-ol Ruthenium Co SHVO'S CATALYST
CAS:104439-77-2
Formula: C62H42O6Ru2
TRC-S282400-100mg
1085.13
Tetracarbonyl-++-hydro[(1,2,3,4,5-++)-1-hydroxy-2,3,4,5-tetraphenyl-2,4-cyclopentadien-1-yl][(2,3,4,5-++)-2,3,4,5-tetraphenyl-2,4-cyclopentadien-1-one]di-ruthenium Coordination Compound; 2,3,4,5-Tetraphenyl-1,3-cyclopentadien-1-ol Ruthenium Co SHVO'S CATALYST
CAS:104439-77-2
Formula: C62H42O6Ru2
TRC-S282400-1g
1085.13
Tetracarbonyl-++-hydro[(1,2,3,4,5-++)-1-hydroxy-2,3,4,5-tetraphenyl-2,4-cyclopentadien-1-yl][(2,3,4,5-++)-2,3,4,5-tetraphenyl-2,4-cyclopentadien-1-one]di-ruthenium Coordination Compound; 2,3,4,5-Tetraphenyl-1,3-cyclopentadien-1-ol Ruthenium Co SILDENAFIL-D8
CAS:951385-68-5
Formula: C22 2H8 H22 N6 O4 S
TRC-S435003-1mg
482.63
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[(4-methyl-1-piperazinyl-2,2,3,3,5,5,6,6-d8); BDD 10402sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl- SILDENAFIL-D8
CAS:951385-68-5
Formula: C22 2H8 H22 N6 O4 S
TRC-S435003-10mg
482.63
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[(4-methyl-1-piperazinyl-2,2,3,3,5,5,6,6-d8); BDD 10402sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl- SILICON 2,3-NAPHTHALOCYANINE DIOCTYLOXIDE
CAS:92941-50-9
Formula: C64 H58 N8 O2 Si
TRC-S456540
999.283
(OC-6-12)-Bis(octyloxy)[37H,39H-tetranaphtho[2,3-b:2',3'-g:2'',3''-l:2''',3'''-q]porphyrazinato(2-)-N37,N38,N39,N40]-silicon; (OC-6-12)-Bis(octyloxy)[37H,39H-tetranaphtho[2,3-b:2',3'-g:2'',3''-l:2''',3'''-q]porphyrazinato(2-)-+¦N37,+¦N38,+¦N39 SILYBIN A
CAS:22888-70-6
Formula: C25 H22 O10
TRC-S465855-1mg
482.44
Silybin; (2R,3R)-2-[(2R,3R)-2,3-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 3,5,7-Trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzod SILYBIN A
CAS:22888-70-6
Formula: C25 H22 O10
TRC-S465855-10mg
482.44
Silybin; (2R,3R)-2-[(2R,3R)-2,3-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 3,5,7-Trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzod SILYBIN A,B (MIXTURE)
CAS:802918-57-6
Formula: C25 H22 O10
TRC-S465850-1g
482.44
4H-1-Benzopyran-4-one, 2-[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-; 4H-1-Benzopyran-4-one, 2-[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-b SILYBIN A,B (MIXTURE)
CAS:802918-57-6
Formula: C25 H22 O10
TRC-S465850-5g
482.44
4H-1-Benzopyran-4-one, 2-[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-; 4H-1-Benzopyran-4-one, 2-[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-b SILYBIN A,B (MIXTURE)
CAS:802918-57-6
Formula: C25 H22 O10
TRC-S465850-2.5g
482.44
4H-1-Benzopyran-4-one, 2-[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-; 4H-1-Benzopyran-4-one, 2-[2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-b SILYBIN A-D3
Formula: C25H19D3O10
TRC-S465857
485.46
(2R,3R)-2-[(2R,3R)-2,3-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one-d3; 3,5,7-Trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxan- SILYBIN B
CAS:142797-34-0
Formula: C25 H22 O10
TRC-S465860-10mg
482.436
4H-1-Benzopyran-4-one, 2-[(2S,3S)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-; 1,4-Benzodioxin, 4H-1-benzopyran-4-one deriv.; (2R,3R)-2-[(2S,3S)-2,3-Dihydro-3-(4- SILYBIN B
CAS:142797-34-0
Formula: C25 H22 O10
TRC-S465860-1mg
482.436
4H-1-Benzopyran-4-one, 2-[(2S,3S)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-; 1,4-Benzodioxin, 4H-1-benzopyran-4-one deriv.; (2R,3R)-2-[(2S,3S)-2,3-Dihydro-3-(4- SILYCHRISTIN
CAS:33889-69-9
Formula: C25 H22 O10
TRC-S465880-10mg
482.44
4H-1-Benzopyran-4-one, 2-[(2R,3S)-2,3-dihydro-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-5-benzofuranyl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-; 4-Chromanone, 2-[2,3-dihydro-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxy SILYCHRISTIN
CAS:33889-69-9
Formula: C25 H22 O10
TRC-S465880-5mg
482.44
4H-1-Benzopyran-4-one, 2-[(2R,3S)-2,3-dihydro-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-5-benzofuranyl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-; 4-Chromanone, 2-[2,3-dihydro-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxy SILYDIANIN
CAS:29782-68-1
Formula: C25 H22 O10
TRC-S465890-10mg
482.44
3,6-Methanobenzofuran-7(6H)-one, 4-[(2R,3R)-3,4-dihydro-3,5,7-trihydroxy-4-oxo-2H-1-benzopyran-2-yl]-2,3,3a,7a-tetrahydro-7a-hydroxy-8-(4-hydroxy-3-methoxyphenyl)-, (3R,3aR,6R,7aR,8R)-; 3,6-Methanobenzofuran-7(6H)-one, 4-(3,4-dihydro-3,5,7- SILYDIANIN
CAS:29782-68-1
Formula: C25 H22 O10
TRC-S465890-5mg
482.44
3,6-Methanobenzofuran-7(6H)-one, 4-[(2R,3R)-3,4-dihydro-3,5,7-trihydroxy-4-oxo-2H-1-benzopyran-2-yl]-2,3,3a,7a-tetrahydro-7a-hydroxy-8-(4-hydroxy-3-methoxyphenyl)-, (3R,3aR,6R,7aR,8R)-; 3,6-Methanobenzofuran-7(6H)-one, 4-(3,4-dihydro-3,5,7- SIMAZINE
CAS:122-34-9
Formula: C7 H12 Cl N5
TRC-S465900-5g
201.66
1,3,5-Triazine-2,4-diamine, 6-chloro-N2,N4-diethyl-; 1,3,5-Triazine-2,4-diamine, 6-chloro-N,N'-diethyl- (9CI); s-Triazine, 2-chloro-4,6-bis(ethylamino)- (8CI); 6-Chloro-N2,N4-diethyl-1,3,5-triazine-2,4-diamine; 2,4-Bis(ethylamino)-6-chloro- SIMAZINE
CAS:122-34-9
Formula: C7 H12 Cl N5
TRC-S465900-10g
201.66
1,3,5-Triazine-2,4-diamine, 6-chloro-N2,N4-diethyl-; 1,3,5-Triazine-2,4-diamine, 6-chloro-N,N'-diethyl- (9CI); s-Triazine, 2-chloro-4,6-bis(ethylamino)- (8CI); 6-Chloro-N2,N4-diethyl-1,3,5-triazine-2,4-diamine; 2,4-Bis(ethylamino)-6-chloro- SIMAZINE-13C5
Formula: 13C5 C2 H12 Cl N5
TRC-S465903
206.62
6-Chloro-N2,N4-diethyl-1,3,5-triazine-2,4-diamine-13C5; 2-Chloro-4,6-bis(ethylamino)-s-triazine-13C5; 2,4-Bis(ethylamino)-6-chloro-s-triazine-13C5; 2,4-Di(ethylamino)-6-chloro-1,3,5-triazine-13C5; 2-Chloro-4,6-bis(ethylamino)-1,3,5-triazine SIMAZINE-D10
CAS:220621-39-6
Formula: C7 2H10 H2 Cl N5
TRC-S465902-25mg
211.72
Simazine D10; 1,3,5-Triazine-2,4-diamine, 6-chloro-N2,N4-di(ethyl-1,1,2,2,2-d5)-; 1,3,5-Triazine-2,4-diamine, 6-chloro-N,N'-di(ethyl-d5)- (9CI); 6-Chloro-N2,N4-di(ethyl-1,1,2,2,2-d5)-1,3,5-triazine-2,4-diamine SIMAZINE-D10
CAS:220621-39-6
Formula: C7 2H10 H2 Cl N5
TRC-S465902-5mg
211.72
Simazine D10; 1,3,5-Triazine-2,4-diamine, 6-chloro-N2,N4-di(ethyl-1,1,2,2,2-d5)-; 1,3,5-Triazine-2,4-diamine, 6-chloro-N,N'-di(ethyl-d5)- (9CI); 6-Chloro-N2,N4-di(ethyl-1,1,2,2,2-d5)-1,3,5-triazine-2,4-diamine SIMEPREVIR
CAS:923604-59-5
Formula: C38 H47 N5 O7 S2
TRC-S466500-50mg
749.94
Cyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide, N-(cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-di SIMEPREVIR
CAS:923604-59-5
Formula: C38 H47 N5 O7 S2
TRC-S466500-5mg
749.94
Cyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide, N-(cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-di SIMEPREVIR-D3
Formula: C38 D3 H44 N5 O7 S2
TRC-S466502
752.958
(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxo-cyclopenta[c]cyclopropa[g][1,6]diazacyclot SIMETRYN
CAS:1014-70-6
Formula: C8 H15 N5 S
TRC-S485070-1g
213.3
1,3,5-Triazine-2,4-diamine, N2,N4-diethyl-6-(methylthio)- (ACI); 1,3,5-Triazine-2,4-diamine, N,N'-diethyl-6-(methylthio)- (9CI); N2,N4-Diethyl-6-(methylthio)-1,3,5-triazine-2,4-diamine (ACI); s-Triazine, 2,4-bis(ethylamino)-6-(methylthio)- SIMETRYN
CAS:1014-70-6
Formula: C8 H15 N5 S
TRC-S485070-250mg
213.3
1,3,5-Triazine-2,4-diamine, N2,N4-diethyl-6-(methylthio)- (ACI); 1,3,5-Triazine-2,4-diamine, N,N'-diethyl-6-(methylthio)- (9CI); N2,N4-Diethyl-6-(methylthio)-1,3,5-triazine-2,4-diamine (ACI); s-Triazine, 2,4-bis(ethylamino)-6-(methylthio)- SIMETRYN
CAS:1014-70-6
Formula: C8 H15 N5 S
TRC-S485070-100mg
213.3
1,3,5-Triazine-2,4-diamine, N2,N4-diethyl-6-(methylthio)- (ACI); 1,3,5-Triazine-2,4-diamine, N,N'-diethyl-6-(methylthio)- (9CI); N2,N4-Diethyl-6-(methylthio)-1,3,5-triazine-2,4-diamine (ACI); s-Triazine, 2,4-bis(ethylamino)-6-(methylthio)- SIMVASTATIN
CAS:79902-63-9
Formula: C25 H38 O5
TRC-S485000-25mg
418.57
Simvastatin; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, 1,2,3,7,8,8a-hexahydro-3,7-di SIMVASTATIN
CAS:79902-63-9
Formula: C25 H38 O5
TRC-S485000-50mg
418.57
Simvastatin; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, 1,2,3,7,8,8a-hexahydro-3,7-di SIMVASTATIN
CAS:79902-63-9
Formula: C25 H38 O5
TRC-S485000-250mg
418.57
Simvastatin; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, 1,2,3,7,8,8a-hexahydro-3,7-di Simvastatin 4GÇÖ-methyl ether
CAS:864357-88-0
Formula: C26 H40 O5
TRC-S485045-50mg
432.59
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-methoxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetr Simvastatin 4GÇÖ-methyl ether
CAS:864357-88-0
Formula: C26 H40 O5
TRC-S485045-25mg
432.59
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-methoxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetr Simvastatin 4GÇÖ-methyl ether
CAS:864357-88-0
Formula: C26 H40 O5
TRC-S485045-5mg
432.59
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-methoxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetr Simvastatin Acyl-beta-D-glucuronide-d6
Formula: C31H48D6O12
TRC-S485004
624.79
1-[(+¦R,+¦R,1S,2S,6R,8S,8aR)-8-(2,2-Dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦-d6, +¦-dihydroxy-2,6-dimethyl-1-naphthaleneheptanoate] +¦-D-Glucopyranuronic Acid-d6; Simvastatin Allyl Ester Acyl-+¦-D-glucuronide
Formula: C34 H52 O12
TRC-S485003
652.769
Allyl (2S,3S,4S,5R,6S)-6-(((3R,5R)-7-((1S,2S,6R,8S,8aR)-8-((2,2-dimethylbutanoyl)oxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylate SIMVASTATIN DIMER
CAS:476305-24-5
Formula: C50 H76 O10
TRC-S485010-1mg
837.13
1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-, (2R,4R)-2-[2-[(1S,2S,6R,8S,8aR)-8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-2,6-dimethyl-1-naphthalenyl]ethyl]tetrahydro-6 SIMVASTATIN DIMER
CAS:476305-24-5
Formula: C50 H76 O10
TRC-S485010-10mg
837.13
1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-, (2R,4R)-2-[2-[(1S,2S,6R,8S,8aR)-8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-2,6-dimethyl-1-naphthalenyl]ethyl]tetrahydro-6 SIMVASTATIN HYDROXY ACID AMMONIUM SALT
CAS:139893-43-9
Formula: C25 H39 O6 . H4 N
TRC-S485020-100mg
453.61
1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-, ammonium salt (1:1), (+¦R,+¦R,1S,2S,6R,8S,8aR)-; 1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦, SIMVASTATIN HYDROXY ACID AMMONIUM SALT
CAS:139893-43-9
Formula: C25 H39 O6 . H4 N
TRC-S485020-10mg
453.61
1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-, ammonium salt (1:1), (+¦R,+¦R,1S,2S,6R,8S,8aR)-; 1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦, SIMVASTATIN HYDROXY ACID AMMONIUM SALT
Formula: C25H43NO6
TRC-S485020-25mg
453.61
(+¦R,+¦R,1S,2S,6R,8S,8aR)-8-(2,2-Dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-1-naphthaleneheptanoic Acid Ammonium Salt; Simvastatin Acid Ammonium Salt; Simvastatin Ammonium Salt; Simvastatin Carboxylic Acid Ammoniu SIMVASTATIN HYDROXY ACID ETHYL ESTER
CAS:864357-87-9
Formula: C27 H44 O6
TRC-S485035-50mg
464.63
1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-, ethyl ester, (+¦R,+¦R,1S,2S,6R,8S,8aR)-; Ethyl (+¦R,+¦R,1S,2S,6R,8S,8aR)-8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihyd SIMVASTATIN HYDROXY ACID ETHYL ESTER
CAS:864357-87-9
Formula: C27 H44 O6
TRC-S485035-10mg
464.63
1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-, ethyl ester, (+¦R,+¦R,1S,2S,6R,8S,8aR)-; Ethyl (+¦R,+¦R,1S,2S,6R,8S,8aR)-8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihyd SIMVASTATIN HYDROXY ACID METHYL ESTER
CAS:145576-26-7
Formula: C26H42O6
TRC-S485015-50mg
450.61
1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-, methyl ester, (+¦R,+¦R,1S,2S,6R,8S,8aR)-; 1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihyd SIMVASTATIN HYDROXY ACID METHYL ESTER
CAS:145576-26-7
Formula: C26H42O6
TRC-S485015-100mg
450.61
1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-, methyl ester, (+¦R,+¦R,1S,2S,6R,8S,8aR)-; 1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihyd SIMVASTATIN HYDROXY ACID METHYL ESTER
CAS:145576-26-7
Formula: C26H42O6
TRC-S485015-10mg
450.61
1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-, methyl ester, (+¦R,+¦R,1S,2S,6R,8S,8aR)-; 1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihyd SIMVASTATIN HYDROXY ACID SODIUM SALT
CAS:101314-97-0
Formula: C25 H39 O6 . Na
TRC-S485050-10mg
458.56
1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-, sodium salt (1:1), (+¦R,+¦R,1S,2S,6R,8S,8aR)-; 1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦- SIMVASTATIN HYDROXY ACID SODIUM SALT
CAS:101314-97-0
Formula: C25 H39 O6 . Na
TRC-S485050-1mg
458.56
1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-, sodium salt (1:1), (+¦R,+¦R,1S,2S,6R,8S,8aR)-; 1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦- SIMVASTATIN HYDROXY ACID SODIUM SALT
CAS:101314-97-0
Formula: C25 H39 O6 . Na
TRC-S485050-25mg
458.56
1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-, sodium salt (1:1), (+¦R,+¦R,1S,2S,6R,8S,8aR)-; 1-Naphthaleneheptanoic acid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦- SIMVASTATIN-D11 (2,2-DIMETHYLBUTYRATE-D11)
CAS:1002347-74-1
Formula: C25 D11 H27 O5
TRC-S485001-5mg
429.634
Butanoic-3,3,4,4,4-d5 acid, 2,2-di(methyl-d3)-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester (ACI); (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dim SIMVASTATIN-D11 (2,2-DIMETHYLBUTYRATE-D11)
CAS:1002347-74-1
Formula: C25 D11 H27 O5
TRC-S485001-10mg
429.634
Butanoic-3,3,4,4,4-d5 acid, 2,2-di(methyl-d3)-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester (ACI); (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dim SIMVASTATIN-D6
CAS:1002347-71-8
Formula: C25H32D6O5
TRC-S485002-2.5mg
424.6
2,2-(Dimethyl-d6)butanoic Acid(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro -3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl] -1-naphthalenyl Ester; (+)-Simvastatin-d6; Cholestat-d6; Lipex-d6; Novo-Simvastatin-d6; Simvo SIMVASTATIN-D6
CAS:1002347-71-8
Formula: C25H32D6O5
TRC-S485002-25mg
424.6
2,2-(Dimethyl-d6)butanoic Acid(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro -3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl] -1-naphthalenyl Ester; (+)-Simvastatin-d6; Cholestat-d6; Lipex-d6; Novo-Simvastatin-d6; Simvo SIMVASTATIN-D6
CAS:1002347-71-8
Formula: C25H32D6O5
TRC-S485002-1mg
424.6
2,2-(Dimethyl-d6)butanoic Acid(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro -3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl] -1-naphthalenyl Ester; (+)-Simvastatin-d6; Cholestat-d6; Lipex-d6; Novo-Simvastatin-d6; Simvo SIMVASTATIN-D6 HYDROXY ACID AMMONIUM SALT
Formula: C25H37D6NO6
TRC-S485022-1mg
459.65
(+¦R,+¦R,1S,2S,6R,8S,8aR)-8-[2,2-(Dimethyl-d6)-1-oxobutoxy]-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-1-naphthaleneheptanoic Acid Ammonium Salt; Simvastatin-d6 Acid Ammonium Salt; Simvastatin-d6 Ammonium Salt; Simvastatin-d6 Carboxyli SIMVASTATIN-D6 HYDROXY ACID AMMONIUM SALT
Formula: C25H37D6NO6
TRC-S485022-10mg
459.65
(+¦R,+¦R,1S,2S,6R,8S,8aR)-8-[2,2-(Dimethyl-d6)-1-oxobutoxy]-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-1-naphthaleneheptanoic Acid Ammonium Salt; Simvastatin-d6 Acid Ammonium Salt; Simvastatin-d6 Ammonium Salt; Simvastatin-d6 Carboxyli SIMVASTATIN-D6 HYDROXY ACID SODIUM SALT
Formula: C25H33D6NaO6
TRC-S484992-10mg
464.6
[1S-[1+¦(+¦S*,+¦S*),2+¦,6+¦,8+¦,8a+¦]]-8-(2,2-Dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-1-naphthaleneheptanoic Acid Monosodium Salt SIMVASTATIN-D6 HYDROXY ACID SODIUM SALT
Formula: C25H33D6NaO6
TRC-S484992-1mg
464.6
[1S-[1+¦(+¦S*,+¦S*),2+¦,6+¦,8+¦,8a+¦]]-8-(2,2-Dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-1-naphthaleneheptanoic Acid Monosodium Salt SINENSETIN
CAS:2306-27-6
Formula: C20 H20 O7
TRC-S487300-25mg
372.37
2-(3,4-Dimethoxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one; 3',4',5,6,7-Pentamethoxyflavone; 5,6,7,3',4'-Pentamethoxyflavone; Pedalitin Permethyl Ether; SINENSETIN
CAS:2306-27-6
Formula: C20 H20 O7
TRC-S487300-10mg
372.37
2-(3,4-Dimethoxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one; 3',4',5,6,7-Pentamethoxyflavone; 5,6,7,3',4'-Pentamethoxyflavone; Pedalitin Permethyl Ether; SINENSETIN
CAS:2306-27-6
Formula: C20 H20 O7
TRC-S487300-100mg
372.37
2-(3,4-Dimethoxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one; 3',4',5,6,7-Pentamethoxyflavone; 5,6,7,3',4'-Pentamethoxyflavone; Pedalitin Permethyl Ether; SINIGRINE
CAS:3952-98-5
Formula: C10 H16 N O9 S2 . K
TRC-S487350-50mg
397.46
+¦-D-Glucopyranose, 1-thio-, 1-[N-(sulfooxy)-3-butenimidate], potassium salt (1:1) (ACI); Glucopyranose, 1-thio-, 1-(3-butenoate), oxime, O-sulfate, potassium salt, +¦-D- (7CI); Glucopyranose, 1-thio-, 1-(3-butenohydroximate) NO-(hydrogen sul SINIGRINE
CAS:3952-98-5
Formula: C10 H16 N O9 S2 . K
TRC-S487350-250mg
397.46
+¦-D-Glucopyranose, 1-thio-, 1-[N-(sulfooxy)-3-butenimidate], potassium salt (1:1) (ACI); Glucopyranose, 1-thio-, 1-(3-butenoate), oxime, O-sulfate, potassium salt, +¦-D- (7CI); Glucopyranose, 1-thio-, 1-(3-butenohydroximate) NO-(hydrogen sul SINIGRINE
CAS:3952-98-5
Formula: C10 H16 N O9 S2 . K
TRC-S487350-100mg
397.46
+¦-D-Glucopyranose, 1-thio-, 1-[N-(sulfooxy)-3-butenimidate], potassium salt (1:1) (ACI); Glucopyranose, 1-thio-, 1-(3-butenoate), oxime, O-sulfate, potassium salt, +¦-D- (7CI); Glucopyranose, 1-thio-, 1-(3-butenohydroximate) NO-(hydrogen sul SINOMENINE HYDROCHLORIDE
CAS:6080-33-7
Formula: C19 H23 N O4 . Cl H
TRC-S487500-500mg
365.85
9+¦,13+¦,14+¦-Morphinan-6-one, 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-, hydrochloride (8CI); Morphinan-6-one, 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-, hydrochloride, (9+¦,13+¦,14+¦)- (9CI); Sinomenine hydrochloride (6CI,7CI); Cu SINOMENINE HYDROCHLORIDE
CAS:6080-33-7
Formula: C19 H23 N O4 . Cl H
TRC-S487500-100mg
365.85
9+¦,13+¦,14+¦-Morphinan-6-one, 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-, hydrochloride (8CI); Morphinan-6-one, 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-, hydrochloride, (9+¦,13+¦,14+¦)- (9CI); Sinomenine hydrochloride (6CI,7CI); Cu SINOMENINE HYDROCHLORIDE
CAS:6080-33-7
Formula: C19 H23 N O4 . Cl H
TRC-S487500-250mg
365.85
9+¦,13+¦,14+¦-Morphinan-6-one, 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-, hydrochloride (8CI); Morphinan-6-one, 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-, hydrochloride, (9+¦,13+¦,14+¦)- (9CI); Sinomenine hydrochloride (6CI,7CI); Cu SITAGLIPTIN
CAS:486460-32-6
Formula: C16H15F6N5O
TRC-S491035-50mg
407.31
1-Butanone, 3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (3R)- (ACI); (3R)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluoro SITAGLIPTIN
CAS:486460-32-6
Formula: C16H15F6N5O
TRC-S491035-500mg
407.31
1-Butanone, 3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (3R)- (ACI); (3R)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluoro SITAGLIPTIN
CAS:486460-32-6
Formula: C16H15F6N5O
TRC-S491035-250mg
407.31
1-Butanone, 3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (3R)- (ACI); (3R)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluoro SITAGLIPTIN PHOSPHATE
CAS:654671-78-0
Formula: C16 H15 F6 N5 O . H3 O4 P
TRC-S491000-250mg
505.31
1-Butanone, 3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (3R)-, phosphate (1:1); 1,2,4-Triazolo[4,3-a]pyrazine, 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-t SITAGLIPTIN PHOSPHATE
CAS:654671-78-0
Formula: C16 H15 F6 N5 O . H3 O4 P
TRC-S491000-100mg
505.31
1-Butanone, 3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (3R)-, phosphate (1:1); 1,2,4-Triazolo[4,3-a]pyrazine, 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-t SITAGLIPTIN PHOSPHATE
CAS:654671-78-0
Formula: C16 H15 F6 N5 O . H3 O4 P
TRC-S491000-50mg
505.31
1-Butanone, 3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (3R)-, phosphate (1:1); 1,2,4-Triazolo[4,3-a]pyrazine, 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-t SITAGLIPTIN TRIAZECINE ANALOG
CAS:2805078-75-3
Formula: C16 H13 F6 N5 O2
TRC-S491015-0.5mg
421.3
10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione SITAGLIPTIN TRIAZECINE ANALOG
CAS:2805078-75-3
Formula: C16 H13 F6 N5 O2
TRC-S491015-5mg
421.3
10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione SITAGLIPTIN TRIAZECINE ANALOG-D4
Formula: C16 D4 H9 F6 N5 O2
TRC-S491017
425.322
10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione-D4 SITAGLIPTIN-D4 PHOSPHATE
CAS:1432063-88-1
Formula: C16 2H4 H11 F6 N5 O . H3 O4 P
TRC-S491002-1mg
509.33
(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-5,5,6,6-tetradeuterio-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate salt; 3(R)-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]py SITAGLIPTIN-D4 PHOSPHATE
CAS:1432063-88-1
Formula: C16 2H4 H11 F6 N5 O . H3 O4 P
TRC-S491002-10mg
509.33
(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-5,5,6,6-tetradeuterio-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate salt; 3(R)-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]py SITOSTANOL-D7 (MIXTURE OF DIASTEROMERS)
Formula: C29 D7 H45 O
TRC-S495002-10mg
423.7657
(3+¦,5+¦,24++)-Stigmastan-3-ol-25,26,26,26,27,27,27-d7; (24++)-24-Ethyl-5+¦-cholestan-3+¦-ol-25,26,26,26,27,27,27-d7; 24-Ethyl-5+¦(H)-cholestan-3+¦-ol-25,26,26,26,27,27,27-d7; 24-Ethylcholestanol-25,26,26,26,27,27,27-d7; 24++-Ethyl-5+¦-cholestan-3+¦-o SITOSTANOL-D7 (MIXTURE OF DIASTEROMERS)
Formula: C29 D7 H45 O
TRC-S495002-1mg
423.7657
(3+¦,5+¦,24++)-Stigmastan-3-ol-25,26,26,26,27,27,27-d7; (24++)-24-Ethyl-5+¦-cholestan-3+¦-ol-25,26,26,26,27,27,27-d7; 24-Ethyl-5+¦(H)-cholestan-3+¦-ol-25,26,26,26,27,27,27-d7; 24-Ethylcholestanol-25,26,26,26,27,27,27-d7; 24++-Ethyl-5+¦-cholestan-3+¦-o SM 406-D3
Formula: C32 D3 H40 N5 O4
TRC-S564032
564.733
(5S,8S,10aR)-N-benzhydryl-3-(3-methylbutanoyl)-6-oxo-5-[[(2S)-2-(trideuteriomethylamino)propanoyl]amino]-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide; SM 406-D3 SMER3
CAS:67200-34-4
Formula: C11 H4 N4 O2
TRC-S564750
224.175
SMER3; 9H-Indeno[1,2-e][1,2,5]oxadiazolo[3,4-b]pyrazin-9-one; 9H-Indeno[1,2-b][1,2,5]oxadiazolo[3,4-e]pyrazin-9-one; 2-Oxa-1,3,4,10-tetraazacyclopenta[b]fluoren-9-one SN(IV) MESOPORPHYRIN IX DICHLORIDE
CAS:106344-20-1
Formula: C34 H36 Cl2 N4 O4 Sn
TRC-T444105
754.29
Sn(IV) Mesoporphyrin IX Dichloride; Stannate(2-), dichloro[7,12-diethyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-+¦N21,+¦N22,+¦N23,+¦N24]-, hydrogen (1:2), (OC-6-13)-; Stannate(2-), dichloro[7,12-diethyl-3,8,13,17-tetramethy SN-38
CAS:86639-52-3
Formula: C22 H20 N2 O5
TRC-S589950-5mg
392.4
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (4S)-; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxy-7-ethylcamptothecin; 7-Ethyl SN-38
CAS:86639-52-3
Formula: C22 H20 N2 O5
TRC-S589950-250mg
392.4
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (4S)-; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxy-7-ethylcamptothecin; 7-Ethyl SN-38
CAS:86639-52-3
Formula: C22 H20 N2 O5
TRC-S589950-50mg
392.4
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (4S)-; (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxy-7-ethylcamptothecin; 7-Ethyl SN-38 4-DEOXY-GLUCURONIDE
Formula: C28H26N2O10
TRC-S589970-0.5mg
550.51
4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-Deoxy-+¦-D-glucopyranosiduronic Acid; (4S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2- SN-38 4-DEOXY-GLUCURONIDE
Formula: C28H26N2O10
TRC-S589970-5mg
550.51
4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-Deoxy-+¦-D-glucopyranosiduronic Acid; (4S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2- SN-38 GLUCURONIDE
CAS:121080-63-5
Formula: C28 H28 N2 O11
TRC-S589980-5mg
568.53
+¦-D-Glucopyranosiduronic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl; +¦-D-Glucopyranosiduronic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3 SN-38 GLUCURONIDE
CAS:121080-63-5
Formula: C28 H28 N2 O11
TRC-S589980-1mg
568.53
+¦-D-Glucopyranosiduronic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl; +¦-D-Glucopyranosiduronic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3 SN-38 GLUCURONIDE
CAS:121080-63-5
Formula: C28 H28 N2 O11
TRC-S589980-10mg
568.53
+¦-D-Glucopyranosiduronic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl; +¦-D-Glucopyranosiduronic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3 SN-38 GLUCURONIDE-D5
Formula: C28 D5 H23 N2 O11
TRC-S589984
573.559
(2S,3S,4S,5R,6S)-6-[[(19S)-10-ethyl-19-hydroxy-14,18-dioxo-19-(1,1,2,2,2-pentadeuterioethyl)-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-7-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid; SN SN-38 Tri-O-acetyl-+¦-D-glucuronic Acid Methyl Ester-d3
Formula: C35 D3 H33 N2 O11
TRC-S589997
663.686
Methyl-(2S,3S,4S,5R,6S)-3,4,5-triacetyl-6-[[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-10-(2,2,2-trideuterioethyl)-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-7-yl]oxy]oxane-2-carboxylate; SN-38 SN-38-D3 GLUCURONIDE
Formula: C28H25D3N2O11
TRC-S589982-0.5mg
571.55
4-Ethyl-11-(ethyl-d3)-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-Deoxy-+¦-D-glucopyranosiduronic Acid; (4S)-4-Ethyl-11-(ethyl-d3)-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6 SN-38-D3 GLUCURONIDE
Formula: C28H25D3N2O11
TRC-S589982-1mg
571.55
4-Ethyl-11-(ethyl-d3)-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-Deoxy-+¦-D-glucopyranosiduronic Acid; (4S)-4-Ethyl-11-(ethyl-d3)-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6 SN-38-D3 GLUCURONIDE
Formula: C28H25D3N2O11
TRC-S589982-5mg
571.55
4-Ethyl-11-(ethyl-d3)-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-Deoxy-+¦-D-glucopyranosiduronic Acid; (4S)-4-Ethyl-11-(ethyl-d3)-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6 Sodium ((2S,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-((2-ethoxy-3,4-dioxocyclobut-1-en-1-yl)amino)-4-hydroxytetrahydrofuran-2-yl)methyl Phosphate
Formula: C15 H16 N3 Na2 O11 P
TRC-S276228
491.254
Sodium ((2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-((2-ethoxy-3,4-dioxocyclobut-1-en-1-yl)amino)-4-hydroxytetrahydrofuran-2-yl)methyl Phosphate Sodium ((2S,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-3-((2-((2-hydroxyethyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)tetrahydrofuran-2-yl)methyl Phosphate
Formula: C15 H17 N4 Na2 O11 P
TRC-S276230
506.269
Sodium ((2S,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-3-((2-((2-hydroxyethyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)tetrahydrofuran-2-yl)methyl Phosphate Sodium ((2S,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-3-((thiophen-2-ylmethyl)amino)tetrahydrofuran-2-yl)methyl Phosphate
Formula: C14 H16 N3 Na2 O8 P S
TRC-S276223
463.31
Sodium ((2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-3-((thiophen-2-ylmethyl)amino)tetrahydrofuran-2-yl)methyl Phosphate Sodium ((2S,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-3-(methylsulfonamido)tetrahydrofuran-2-yl)methyl Phosphate
Formula: C10 H14 N3 Na2 O10 P S
TRC-S276225
445.251
Sodium ((2S,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-3-(methylsulfonamido)tetrahydrofuran-2-yl)methyl Phosphate Sodium ((2S,3S,5R)-3-((2-((2-Hydroxyethyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl Phosphate
Formula: C16 H19 N4 Na2 O10 P
TRC-S276240
504.296
Sodium ((2S,3S,5R)-3-((2-((2-Hydroxyethyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl Phosphate Sodium ((2S,3S,5R)-3-((2-(Diethylamino)-3,4-dioxocyclobut-1-en-1-yl)amino)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl Phosphate
Formula: C18 H23 N4 Na2 O9 P
TRC-S276238
516.35
Sodium ((2S,3S,5R)-3-((2-(Diethylamino)-3,4-dioxocyclobut-1-en-1-yl)amino)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)Methyl Phosphate Sodium ((2S,3S,5R)-3-((2-Ethoxy-3,4-dioxocyclobut-1-en-1-yl)amino)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl Phosphate
Formula: C16 H18 N3 Na2 O10 P
TRC-S276235
489.281
Sodium ((2S,3S,5R)-3-((2-Ethoxy-3,4-dioxocyclobut-1-en-1-yl)amino)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl Phosphate SODIUM (1H,1H,2H,2H-PERFLUOROOCTYL-1H,1H,2H,2H-PERFLUORODECYL)PHOSPHATE
Formula: C18 H7 F30 Na2 O4 P
TRC-S362495
934.151
Sodium 1,1,1,2,2,3,3,4,4,5,5,6,6,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18,18-Triacontafluorooctadecan-9-yl phosphate Sodium 1,1,1,2,2,3,3,4,4,5,5,6,6,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18,18-Triacontafluorooctadecan-9-yl Phosphate
Formula: C18H7F30Na2O4P
TRC-S457910
934.2
Sodium (1H,1H,2H,2H-Perfluorooctyl-1H,1H,2H,2H-perfluorodecyl)phosphate SODIUM 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-NONADECAFLUORONONANE-1-SULFINATE
CAS:306770-96-7
Formula: C9 F19 Na O2 S
TRC-S632585
556.12
1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-Nonadecafluoro-1-nonanesulfinic Acid Sodium Salt SODIUM 1,6,6-TRIMETHYL-10,11-DIOXO-6,7,8,9,10,11-HEXAHYDROPHENANTHRO[1,2-B]FURAN-2-SULFONATE
CAS:69659-80-9
Formula: C19H17NaO6S
TRC-S673785-50mg
396.39
6,7,8,9,10,11-Hexahydro-1,6,6-trimethyl-10,11-dioxo-phenanthro[1,2-b]furan-2-sulfonic Acid Sodium Salt (1:1); DS 201; Sodium Tanshinone IIA Sulfonate; Sulfotanshinone Sodium II-A; Tanshinone IIA Sodium Sulfonate; SODIUM 1,6,6-TRIMETHYL-10,11-DIOXO-6,7,8,9,10,11-HEXAHYDROPHENANTHRO[1,2-B]FURAN-2-SULFONATE
CAS:69659-80-9
Formula: C19H17NaO6S
TRC-S673785-10mg
396.39
6,7,8,9,10,11-Hexahydro-1,6,6-trimethyl-10,11-dioxo-phenanthro[1,2-b]furan-2-sulfonic Acid Sodium Salt (1:1); DS 201; Sodium Tanshinone IIA Sulfonate; Sulfotanshinone Sodium II-A; Tanshinone IIA Sodium Sulfonate; SODIUM 1,6,6-TRIMETHYL-10,11-DIOXO-6,7,8,9,10,11-HEXAHYDROPHENANTHRO[1,2-B]FURAN-2-SULFONATE
CAS:69659-80-9
Formula: C19H17NaO6S
TRC-S673785-25mg
396.39
6,7,8,9,10,11-Hexahydro-1,6,6-trimethyl-10,11-dioxo-phenanthro[1,2-b]furan-2-sulfonic Acid Sodium Salt (1:1); DS 201; Sodium Tanshinone IIA Sulfonate; Sulfotanshinone Sodium II-A; Tanshinone IIA Sodium Sulfonate; SODIUM 17BETA-ESTRADIOL-2,4,16,16-D4 3-SULFATE (STABILIZED WITH TRIS, 50% W/W)
CAS:352431-50-6
Formula: C18 D4 H19 O5 S . Na
TRC-E888826-0.2mg
378.452
Sodium 17+¦-estradiol-2,4,16,16-d4 3-sulfate; (17+¦)-17-Hydroxyestra-1,3,5(10)-trien-3-yl-2,4,16,16-d4 hydrogen sulfate sodium salt; 2,4,16,16-Tetradeuterio-1,3,5(10)-estratriene-3,17+¦-diol-3-sulfate sodium salt; 17+¦-Estradiol-2,4,16,16-d4 3- SODIUM 17BETA-ESTRADIOL-2,4,16,16-D4 3-SULFATE (STABILIZED WITH TRIS, 50% W/W)
CAS:352431-50-6
Formula: C18 D4 H19 O5 S . Na
TRC-E888826-0.4mg
378.452
Sodium 17+¦-estradiol-2,4,16,16-d4 3-sulfate; (17+¦)-17-Hydroxyestra-1,3,5(10)-trien-3-yl-2,4,16,16-d4 hydrogen sulfate sodium salt; 2,4,16,16-Tetradeuterio-1,3,5(10)-estratriene-3,17+¦-diol-3-sulfate sodium salt; 17+¦-Estradiol-2,4,16,16-d4 3- SODIUM 17BETA-ESTRADIOL-2,4,16,16-D4 3-SULFATE (STABILIZED WITH TRIS, 50% W/W)
CAS:352431-50-6
Formula: C18 D4 H19 O5 S . Na
TRC-E888826-2mg
378.452
Sodium 17+¦-estradiol-2,4,16,16-d4 3-sulfate; (17+¦)-17-Hydroxyestra-1,3,5(10)-trien-3-yl-2,4,16,16-d4 hydrogen sulfate sodium salt; 2,4,16,16-Tetradeuterio-1,3,5(10)-estratriene-3,17+¦-diol-3-sulfate sodium salt; 17+¦-Estradiol-2,4,16,16-d4 3- SODIUM 1H,1H,2H,2H-PERFLUOROHEXANE SULFONATE
CAS:27619-93-8
Formula: C6 H4 F9 O3 S . Na
TRC-S673200-5mg
350.13
1-Hexanesulfonic acid, 3,3,4,4,5,5,6,6,6-nonafluoro-, sodium salt (1:1); 1-Hexanesulfonic acid, 3,3,4,4,5,5,6,6,6-nonafluoro-, sodium salt (8CI,9CI); 1H,1H,2H,2H-Perfluorohexanesulfonic acid sodium SODIUM 1H,1H,2H,2H-PERFLUOROHEXANE SULFONATE
CAS:27619-93-8
Formula: C6 H4 F9 O3 S . Na
TRC-S673200-50mg
350.13
1-Hexanesulfonic acid, 3,3,4,4,5,5,6,6,6-nonafluoro-, sodium salt (1:1); 1-Hexanesulfonic acid, 3,3,4,4,5,5,6,6,6-nonafluoro-, sodium salt (8CI,9CI); 1H,1H,2H,2H-Perfluorohexanesulfonic acid sodium SODIUM 1H,1H,2H,2H-PERFLUOROHEXANE SULFONATE
CAS:27619-93-8
Formula: C6 H4 F9 O3 S . Na
TRC-S673200-25mg
350.13
1-Hexanesulfonic acid, 3,3,4,4,5,5,6,6,6-nonafluoro-, sodium salt (1:1); 1-Hexanesulfonic acid, 3,3,4,4,5,5,6,6,6-nonafluoro-, sodium salt (8CI,9CI); 1H,1H,2H,2H-Perfluorohexanesulfonic acid sodium SODIUM 2,2'-METHYLENE-BIS(4,6-DI-TERT-BUTYLPHENYL)PHOSPHATE
CAS:85209-91-2
Formula: C29 H42 O4 P . Na
TRC-S645300-10g
508.6
12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (9CI); 2,2'-Methylenebis(4,6-di-tert-butylphenol) phosphate sodium salt; 2,2'-Methylenebis(4,6-di-tert-butylphenyl)phosphate sodiu SODIUM 2,2'-METHYLENE-BIS(4,6-DI-TERT-BUTYLPHENYL)PHOSPHATE
CAS:85209-91-2
Formula: C29 H42 O4 P . Na
TRC-S645300-1g
508.6
12H-Dibenzo[d,g][1,3,2]dioxaphosphocin, 2,4,8,10-tetrakis(1,1-dimethylethyl)-6-hydroxy-, 6-oxide, sodium salt (9CI); 2,2'-Methylenebis(4,6-di-tert-butylphenol) phosphate sodium salt; 2,2'-Methylenebis(4,6-di-tert-butylphenyl)phosphate sodiu |
